Literature DB >> 22261545

The association of V249I and T280M fractalkine receptor haplotypes with disease course of multiple sclerosis.

Ljiljana Stojković1, Tamara Djurić, Aleksandra Stanković, Evica Dinčić, Olja Stančić, Nevena Veljković, Dragan Alavantić, Maja Zivković.   

Abstract

We investigated the association of CX3CR1 genotypes/haplotypes with MS and performed the prediction analysis of protein sequence variants' effects on CX3CL1/CX3CR1 interaction. We found no association of CX3CR1 with MS susceptibility. Frequency of I(249)T(280) haplotype was significantly lower in SP compared to RR patients (RR>10 years, OR=0.30, 95%CI=0.11-0.79, p=0.01; OR=0.53, 95%CI=0.18-1.56, p=0.2, in SP<10 years vs. RR>10 years). Prediction analysis showed that I249 T280 protein variant would significantly affect CX3CL1/CX3CR1 interaction. Our results suggest that CX3CR1 I₂₄₉T₂₈₀ haplotype could have protective effect for switch to SP MS. Further research is warranted to validate and replicate currently observed results.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22261545     DOI: 10.1016/j.jneuroim.2011.12.028

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  8 in total

1.  Protective effects of CX3CR1 on autoimmune inflammation in a chronic EAE model for MS through modulation of antigen-presenting cell-related molecular MHC-II and its regulators.

Authors:  Weihua Mai; Xingwei Liu; Junfeng Wang; Jing Zheng; Xiao Wang; Wenying Zhou
Journal:  Neurol Sci       Date:  2019-01-23       Impact factor: 3.307

2.  Defective fractalkine-CX3CR1 signaling aggravates neuroinflammation and affects recovery from cuprizone-induced demyelination.

Authors:  Andrew S Mendiola; Kaira A Church; Sandra M Cardona; Difernando Vanegas; Shannon A Garcia; Wendy Macklin; Sergio A Lira; Richard M Ransohoff; Erzsebet Kokovay; Chin-Hsing Annie Lin; Astrid E Cardona
Journal:  J Neurochem       Date:  2022-05-12       Impact factor: 5.546

3.  Regulation of adaptive immunity by the fractalkine receptor during autoimmune inflammation.

Authors:  Jenny A Garcia; Paula A Pino; Makiko Mizutani; Sandra M Cardona; Israel F Charo; Richard M Ransohoff; Thomas G Forsthuber; Astrid E Cardona
Journal:  J Immunol       Date:  2013-07-01       Impact factor: 5.422

Review 4.  Neuron-glia crosstalk in health and disease: fractalkine and CX3CR1 take centre stage.

Authors:  Graham K Sheridan; Keith J Murphy
Journal:  Open Biol       Date:  2013-12-18       Impact factor: 6.411

Review 5.  Microglia and Aging: The Role of the TREM2-DAP12 and CX3CL1-CX3CR1 Axes.

Authors:  Carmen Mecca; Ileana Giambanco; Rosario Donato; Cataldo Arcuri
Journal:  Int J Mol Sci       Date:  2018-01-22       Impact factor: 5.923

Review 6.  Microglial Responses to Brain Injury and Disease: Functional Diversity and New Opportunities.

Authors:  Junxuan Lyu; Xiaoyan Jiang; Rehana K Leak; Yejie Shi; Xiaoming Hu; Jun Chen
Journal:  Transl Stroke Res       Date:  2020-10-31       Impact factor: 6.829

Review 7.  CX3CL1/CX3CR1 in Alzheimer's Disease: A Target for Neuroprotection.

Authors:  Peiqing Chen; Wenjuan Zhao; Yanjie Guo; Juan Xu; Ming Yin
Journal:  Biomed Res Int       Date:  2016-06-27       Impact factor: 3.411

8.  Role of the Fractalkine Receptor in CNS Autoimmune Inflammation: New Approach Utilizing a Mouse Model Expressing the Human CX3CR1I249/M280 Variant.

Authors:  Sandra M Cardona; Sangwon V Kim; Kaira A Church; Vanessa O Torres; Ian A Cleary; Andrew S Mendiola; Stephen P Saville; Stephanie S Watowich; Jan Parker-Thornburg; Alejandro Soto-Ospina; Pedronel Araque; Richard M Ransohoff; Astrid E Cardona
Journal:  Front Cell Neurosci       Date:  2018-10-17       Impact factor: 5.505

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.